Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001553350-17-000661
Filing Date
2017-05-22
Accepted
2017-05-22 15:19:43
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT mdxl_10k.htm 10-K/A 548662
2 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 mdxl_ex31z1.htm EX-31.1 8832
3 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 mdxl_ex31z2.htm EX-31.2 8831
4 CERTIFICATION PURSUANT TO 18 U.S.C. 1350 mdxl_ex32z1.htm EX-32.1 6291
  Complete submission text file 0001553350-17-000661.txt   573766
Mailing Address 2929 EAST COMMERCIAL BLVD PH-D FT LAUDERDALE FL 33308
Business Address 2929 EAST COMMERCIAL BLVD PH-D FT LAUDERDALE FL 33308 954-440-4678
MediXall Group, Inc. (Filer) CIK: 0001601280 (see all company filings)

EIN.: 330864127 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-194337 | Film No.: 17860733
SIC: 7374 Services-Computer Processing & Data Preparation